Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could donor immune cells beat a rare brain infection?

NCT ID NCT02694783

First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 21 times

Summary

This early-phase study tested whether giving special immune cells (PyVST) from a healthy relative could safely treat progressive multifocal leukoencephalopathy (PML), a serious brain infection in people with weakened immune systems. Sixty adults with PML received up to three infusions of these lab-grown virus-killing cells. The main goal was to check safety and feasibility, with secondary aims to see if brain lesions and symptoms improved.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.